Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Prevalence of obstructive sleep apnoea in acute coronary syndrome patients: systematic review and meta-analysis

BMC Cardiovascular Disorders volume 20, Article number: 147 (2020) Cite this article

Abstract

Background

Obstructive Sleep Apnoea (OSA) has been recognised as a risk factor for cardiovascular diseases such as hypertension and cardiovascular events such as acute coronary syndrome (ACS). Since it is also known to reduce exercise tolerance, it is important to establish the prevalence of OSA in ACS patients, particularly in those who are commencing cardiac rehabilitation (CR) programs.

Methods

Using PRISMA guidelines a systematic search was conducted in order to identify studies that objectively measured (using polysomnography or portable monitoring) the prevalence of OSA in ACS patients following hospital admission. A data extraction table was used to summarise study characteristics and the quality of studies were independently assessed using the Joanna Briggs Institute Prevalence Critical Appraisal Tool. Meta-analysis of the selected studies was conducted in order to estimate OSA prevalence as a function of the two main methods of measurement, the severity of OSA, and timing of the OSA assessment following ACS hospital admission.

Results

Pooled prevalence estimates of OSA using the “gold standard” polysomnography ranged from 22% for severe OSA to 70% for mild OSA, at any time after hospital admission. Similar prevalence estimates were obtained using portable monitoring, but interpretation of these results are limited by the significant heterogeneity observed among these studies.

Conclusions

Prevalence of OSA following ACS is high and likely to be problematic upon patient entry into CR programs. Routine screening for OSA upon program entry may be necessary to optimise effectiveness of CR for these patients.

Peer Review reports

Background

Obstructive sleep apnoea (OSA) describes a syndrome of nocturnal respiratory interruptions resulting in sleep fragmentation, daytime hypersomnolence, and oxyhaemoglobin desaturation, usually unrecognized by the patient [1]. The prevalence of OSA in the general population varies significantly according to variations in diagnostic criteria [2], but is estimated to be close to one in five adults [3]. The risk of OSA rises with increasing body weight; active smoking; diabetes; and age [4] and is associated with elevated risk of coronary heart disease (CHD).

Failure to manage OSA may also be of particular importance in secondary prevention of CHD. There is evidence that cardiac rehabilitation (CR) programs that include an exercise training component may improve cardiorespiratory fitness, lifestyle risk factor management, psychosocial health and potentially reduce the risk of recurrent heart attacks. More specifically, there is convincing evidence for the existence of a dose-response gradient between volume of exercise and clinical outcomes in CR patients [5, 6]. Since it is known to reduce exercise tolerance [7, 8], and therefore volume of exercise, OSA may function as a potential barrier to effective CR. Indeed, a number of studies with acute coronary syndrome (ACS) patients, have demonstrated how continued sleep problems can adversely affect postoperative recovery, morbidity, and quality of life [9,10,11].

In order to investigate the prevalence of OSA it is important to identify the methods for measuring its prevalence in epidemiological studies. The “gold standard” test for diagnosis of OSA is a conventional, fully supervised, level I polysomnography (PSG) sleep study [12] but since referral for PSG can be difficult, inconvenient, and expensive [13], unattended portable level II to level IV devices are often utilised instead. In addition, the severity of OSA is quantified by the apnoea-hypopnoea index (AHI), which is the number of breathing cessations (apnoea) and reduced airflow (hypopnoea) events per hour. An AHI of 5–15 indicates mild disease, 15–30 indicates moderate disease, and > 30 indicates severe disease [14]. Any estimate of prevalence must clearly indicate which of these objective measures and which AHI cut-offs are used to define OSA.

In addition to the variation in assessment equipment and severity, much of the variability in prevalence estimations is due to variations in timing of the assessment in relation to the ACS event or surgical procedure. In the short-term, physical and emotional recovery is generally faster when percutaneous coronary intervention (PCI) I is performed in comparison to coronary artery bypass graft surgery(CABGS), but this difference usually dissipates by 12-months post-procedure [15]. There is also some evidence that this improvement over time in physical function and more specifically cardiac function, such as improved ejection fraction, is associated with significant reduction of OSA severity over the first 6 months post-procedure [16, 17]. Variations in OSA prevalence would therefore be expected at these key times: pre-procedure (before surgery), post-procedure (in the few days after surgery), recovery (in the immediate 2–8 weeks after surgery, usually when patients are expected to commence CR or long-term (more than 2 months after surgery).

Secondary analysis of CR patient data has indicated that sleep disorders such as OSA have the potential to hamper rehabilitation efforts by affecting treatment adherence, self-efficacy and psychological wellbeing [18]. Until recently [19, 20], OSA has rarely been mentioned as a risk factor to be managed among cardiac patients. The widespread absence of OSA as a target for screening in CR may be due to the relative paucity of prevalence data in this population. Currently, recommendations and decisions for OSA screening in cardiac patients is based on estimates derived from individual disparate studies. Determination of robust estimates of OSA prevalence in ACS patients via the highest level of evidence, a rigorous systematic review and meta-analysis, would therefore be an important and novel contribution to the evidence base.

Method

We conducted this meta-analysis in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P) statement [21]. The checklist of the PRISMA-P guidelines has been included in the supplemental material (Additional file 1).

Search strategy

We searched the following electronic bibliographic databases: MEDLINE, Embase, CINAHL, the Cochrane Library, and Google Scholar. The search strategy included medical subject heading (MeSH) terms relating to obstructive sleep apnoea and acute coronary syndrome (see Additional file 2). Boolean operators, such as “AND” and “OR”, were used to combine search terms as necessary. The search years covered the period 1995 to April 2019, and there were no language restrictions. This systematic review is registered on Prospero (http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017057948).

Inclusion and exclusion criteria

Observational studies which consist of either cross-sectional, cohort or case-control studies of at least n = 30 ACS patients (unstable angina, ST elevation myocardial infarction, non-ST segment elevation myocardial infarction) within 6 months of hospital admission were included. Since central sleep apnoea is a common occurrence in addition to OSA in heart failure patients, studies that primarily examined heart failure patients were excluded. Studies that provided a total sample of less than 30 participants were excluded. Also, excluded from the analysis were studies that failed to provide sufficient detail regarding definition of OSA, did not provide AHI cut-off details or did not provide a prevalence estimate. Where multiple publications arose from a single study, the primary research paper with the largest sample size was chosen for inclusion.

Quality assessment

Four reviewers (MLG, AJ, AB, AD) independently judged the eligibility of all studies. The risk of bias was systematically evaluated in each eligible study using the Joanna Briggs Institute (JBI) Prevalence Critical Appraisal Tool [22] . This tool is a ten-item questionnaire with four possible responses: yes, no, unclear or not applicable, that assesses limitations related to study design and study population, proportion lost to follow-up, degree of adequate compliance, adjustment for potential confounding factors, and possible conflicts of interest. All articles were reviewed by at least two authors (MLG & AJ). Disagreements between reviewers were resolved by consensus.

Meta-analysis

Data synthesis was conducted using meta-analysis of proportions via the metaprop command in Stata SE 14.2 23 and reported in tables and Forest plots. The random-effects model was chosen apriori, since it takes into account differences in study population, and study designs [23] which are assumed to be similar in a fixed methods model. The heterogeneity between studies was assessed using I2 statistic with values 0–30%, more than 30 to 60% and more than 60% corresponding to low, moderate and high degree of heterogeneity [24]. To explore potential sources of heterogeneity, sensitivity and subgroup analyses of the prevalence were carried out. Sensitivity analyses were conducted to examine the effect of study quality, by using a method similar to that employed by Patsopoulos and colleagues [25] which involves comparing the pooled prevalence before and after elimination of studies with a rating less than 7/10. Subgroup analysis was conducted where there were sufficient numbers and were categorised by primary OSA assessment technique (PSG versus portable monitor), time of assessment (in hospital versus at least 2 months post-hospitalisation) and assessment during CR program attendance A p value of < 0.05 indicated significant heterogeneity between studies [26]. Meta-regression was performed to determine whether possible covariates such as the timing of assessment, sample size, mean age, proportion of women, and study quality could explain the heterogeneity between studies. To assess publication bias among the studies included in the meta-analysis, asymmetry of funnel plots was assessed using Begg’s rank correlation analysis and linear regression analysis (Egger’s method). Since prevalence of OSA during CR was of particular interest a subset of studies that included prevalence estimates at any time during CR was identified for further analysis.

Results

Characteristics of the included studies

A total of 552 articles were retrieved by literature search (Fig. 1) Of these 128 were screened and 75 retained for full-text evaluation. Finally, after a detailed full-text evaluation using the JBI Prevalence Critical Appraisal Tool (see additional file 3) a total of 40 articles published between 1997 and May 2019 were included in the meta-analysis.

Fig. 1
figure 1

Process of identifying studies for inclusion in the review and meta-analysis

Full size image

Summary details of the included studies are shown in Table 1 with further details of studies that provided prevalence estimates in Additional file 4. Countries from all regions of the world were represented, with most studies located in North America, South East Asia and Europe. The majority of studies were observational prospective cohort or case-control designs. Approximately two thirds of the selected studies used portable monitoring rather than polysomnography and a number of these assessed more than one level of OSA severity. Assessment was most commonly conducted within the first week of hospitalisation and females represented just one-fifth (20.6%) of all patients.

Table 1 Characteristics of studies included for the prevalence estimates
Full size table

OSA prevalence estimates

The meta-analysis calculated the pooled prevalence of OSA mild (AHI > 5), moderate-to-severe (AHI > 15), and severe (AHI > 30) in ACS patients assessed by either polysomnography (Fig. 2) or portable home monitoring (Fig. 3) following surgical intervention. Similar pooled prevalence estimates for OSA were obtained for both methods at the moderate (close to half of all patients for both) and severe cut-off levels (over a fifth of all patients) (see Table 2). Study heterogeneity was acceptable for the polysomnography estimates but was moderate to high for portable monitoring.

Fig. 2
figure 2

Forest plot of OSA prevalence in studies using polysomnography by OSA severity sub-groups (Mild AHI =5–14; Moderate AHI = 15–29; Severe AHI > 30) post-surgical intervention. ES = effect size; OSA = obstructive sleep apnoea; AHI = apnoea/hypoxia index. See Additional File 4 for references

Full size image
Fig. 3
figure 3

Forest plot of OSA prevalence in studies using portable monitoring by OSA severity sub-groups (Mild AHI =5–14; Moderate AHI = 15–29; Severe AHI > 30) post-surgical intervention. ES = effect size; OSA = obstructive sleep apnoea; AHI = apnoea/hypoxia index. See Additional File 4 for references

Full size image
Table 2 Prevalence estimates as a function of OSA severity and method of assessment
Full size table

Sensitivity analyses

The sensitivity analysis revealed no significant changes to the prevalence estimates when lower quality studies were removed (Table 2). Further, a meta-regression indicated that JBI quality of study rating did not significantly influence prevalence estimates (β = − 0.007 (95% CI − 0.038 to 0.024), p = 0.650). The effect of timing of OSA assessment was also examined (Table 3). The prevalence of mild OSA using polysomnography within 2 weeks of the ACS event, was 5% lower than at greater than 2 weeks of the OSA event. Using portable monitoring, a significant rise (13%) in mild OSA prevalence was observed over time. In contrast, for the moderate OSA estimates, there were decreases in the prevalence estimate over time, 8% using polysomnography and 1% using portable monitoring. The severe OSA estimates increased by 2%. A regression analysis on the effect of timing on the moderate OSA prevalence estimate using portable monitoring revealed a negative slope (β = − 0.05) with estimates declining over time but this was not significant (p = 0.851). Using the data restricted to moderate OSA, a meta-regression was also performed using percentage of female participants in each study. There was a significant negative slope β = − 0.05 (95% CI − 0.009 to − 0.002), p = 0.002) indicating that prevalence estimates decreased as percentage of females increased (see Fig. 4).

Table 3 Effect of time of assessment after surgical procedure on prevalence estimate
Full size table
Fig. 4
figure 4

Meta-regression of percentage female included in each study and effect on moderate OSA (AHI 15–29) prevalence estimate. OSA = obstructive sleep apnoea; AHI = apnoea/hypoxia index

Full size image

Publication bias

No significant publication bias was detected using either Begg’s or Egger’s methods for assessing funnel plot asymmetry (Table 2). method. Further, visual inspection of the funnel plots indicated that they were symmetrical.

Probability of OSA upon entry to CR programs

Four studies had assessed the probability of an OSA diagnosis associated with attendance at CR programs, but only two had made the assessments upon entry to CR (Table 4). Estimates of those at risk of OSA upon CR entry ranged from 53 to 65% of participants. When portable monitoring was utilised estimates of mild OSA ranged from 44 to 66%, and moderate to high OSA ranged from 33 to 75%. The one study that utilised polysomnography [27] found that close to three-quarters of participants had a diagnosis of mild OSA upon entry to the CR program. In accordance with the overall PSG and portable monitoring prevalence estimates for all ACS patients, the study using Holter ECG monitoring [28] classified 50% of the CR patients as having at least moderate to severe OSA before entry into CR (see Table 4).

Table 4 Prevalence of self-reported OSA in CR settings.
Full size table

Discussion

This meta-analysis confirmed a high prevalence of OSA in ACS patients that persisted within the first six weeks following hospital admission. Close to two-thirds of ACS patients exhibited mild to moderate OSA. What are the mechanisms that could potentially explain this high prevalence level in ACS patients? It is though that the prominent features of OSA, intermittent hypoxia and sleep fragmentation, could affect a number of pathophysiological pathways including metabolic dysfunction [29], sympathetic activation [30], inflammation [31] and oxidative stress [32]. It is known that even mild levels of OSA with minimal daytime symptoms are associated with adverse effects on endothelial function and hypertension [33, 34]. Importantly, higher risk of recurrent ACS has been found at this mild AHI cut-off level compared to patients with no symptoms of OSA [35]. Alarmingly, close to half of all patients were diagnosed with moderate to severe OSA, a level that has been independently associated with 2.3 times the risk of recurrent ACS events after adjusting for covariates such as age, sex, BMI, smoking and diabetes [36].

A second major finding from this study concerns the method of diagnosis of OSA. Remarkably similar estimates of prevalence were obtained using level I “gold standard” polysomnography and levels II to IV portable monitoring, particularly at the moderate and severe AHI levels. A recent review of OSA assessment in CVD patients reported considerable intra-individual night-to-night variability in AHI assessed by polysomnography, with variability particularly higher in patients with mild OSA [37]. These findings would imply that longer periods of assessment, certainly greater than just one night, are warranted in order to gain a more accurate diagnosis of OSA or days of burden with OSA. Given the high congruence in prevalence estimates obtained in this study, the night to night variability of AHI, and the considerable expense associated with polysomnography over a number of nights, it may therefore be of more practical benefit to utilise those portable monitoring devices which have been found to have good predictive validity [38] in long term OSA assessment of ACS patients.

Given the high OSA prevalence estimates obtained in this study it is important to consider the potential implications for screening of this condition upon entry to CR programs. A recent systematic review of exercise-based CR programs reported a null effect of such programs on mortality outcomes [39]. In response to this review it has been pointed out that exercise dose and adherence to exercise may have varied significantly across individual trials, a factor that could explain the heterogeneity in exercise capacity observed across trials and partially explain the overall null finding [40]. The high prevalence of OSA observed in patients attending CR, as noted in this study (Table 4), would contribute to this heterogeneity of exercise adherence and exercise capacity [7, 8] and undermine the effectiveness of exercise-based CR programs. In addition, recent meta-analyses have indicated significant reductions in cardiovascular morbidity [41] and mortality [42] following continuous positive airway pressure (CPAP) treatment where adequate adherence was observed. Given the increased risk for recurrent ACS and the potentially reduced effectiveness of exercise-based CR treatment it would make sense to screen for this condition upon entry to out-patient cardiac rehabilitation programs [19].

There are several potential limitations of this review that should be addressed. First, the vast majority of studies selected in this review included studies based in hospital coronary care units. It was not possible to perform a sub-group analysis on patients attending CR which is typically 4–8 weeks after hospital discharge. In keeping with previous findings [16, 17], our meta-regression findings indicated that OSA prevalence estimates tend to decline slightly in the weeks following hospital admission, however this is not a significant decrease. Individual studies that utilised objective measurement [27, 43, 44] and questionnaires [45,46,47] support the conclusion that OSA prevalence is high upon entry to CR programs. Second, our meta-regression confirmed that any estimate of OSA prevalence is influenced by gender mix, with lower prevalence rates obtained when greater percentages of females are included in the study. The majority of studies selected in this review include predominantly male patients and there were not enough studies to conduct a meta-analysis where equal gender balance was reported. It is known that women are less likely to be referred for revascularization for ACS than men [48], so it is likely that this issue will persist in future studies. Third, due to lack of specific reporting of OSA by diagnostic category in the majority of studies, we were not able to perform sub-group analysis comparing levels of severity of ACS severity. Limited evidence does suggest that severity of OSA may be marginally higher in CABGS patients than PCI patients [49, 50], however this is confounded by insufficient testing in patients who perceive themselves to be asymptomatic and do not participate in studies [49].

Finally, it is important to acknowledge the considerable heterogeneity across the studies included, particularly among studies that utilised portable monitoring. Efforts to account for this heterogeneity including sub-group analysis could not effectively reduce heterogeneity statistics obtained. Given the large variety of type II through to type IV portable devices utilised with varied number of channels recorded [51], varying predictive validity [38], used by different health professionals and the variety of conditions in which they were utilised (e.g. at home, in hospital, expert assisted or not) it may not be possible to effectively control for this study heterogeneity. It is important to note that acceptable heterogeneity was observed for polysomnography where similar prevalence estimates were obtained. Finally, the traumatisation of hospitalisation and surgical intervention is often associated with sleep disturbances which can include OSA and insomnia.

Conclusions

OSA was found to be highly prevalent in ACS patients immediately following surgical intervention and remains high in the period where entry to CR programs is typical. Given the evidence that OSA has a deleterious impact upon exercise capacity and adherence and adversely affect CR efforts,, but can be effectively treated, it may be advisable to screen for this condition upon CR program entry.

Availability of data and materials

The datasets supporting the conclusions of the study are included in the article. Any additional data will be available on request. Michael Le Grande should be contacted to request the data.

Abbreviations

OSA:

Obstructive sleep apnoea

ACS:

Acute coronary syndrome

CHD:

Coronary heart disease

CR:

Cardiac rehabilitation

AHI:

Apnoea-hypoxia index

PSG:

Polysomnography

PCI:

Percutaneous coronary intervention

CABGS:

Coronary artery bypass graft surgery

BMI:

Body mass index

References

  1. Hauri P. The international classification of sleep disorders, diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.

    Google Scholar 

  2. Adams R, Appleton S, Vakulin A, et al. Prevalence of obstructive sleep apnea syndrome (OSAS) in men varies markedly according to definition criteria. Eur Respir J. 2016;48:PA2325.

    Google Scholar 

  3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.

    Article  CAS  PubMed  Google Scholar 

  4. Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237–45.

    Article  PubMed  Google Scholar 

  5. Santiago de Araujo Pio C, Marzolini S, Pakosh M, Grace SL. Effect of cardiac rehabilitation dose on mortality and morbidity: a systematic review and meta-regression analysis. Mayo Clin Proc. 2017;92:1644–59.

    Article  PubMed  Google Scholar 

  6. Taylor C, Tsakirides C, Moxon J, et al. Exercise dose and all-cause mortality within extended cardiac rehabilitation: a cohort study. Open Heart. 2017;4:e000623.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Beitler JR, Awad KM, Bakker JP, et al. Obstructive sleep apnea is associated with impaired exercise capacity: a cross-sectional study. J Clin Sleep Med. 2014;10:1199–204.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Przybylowski T, Bielicki P, Kumor M, et al. Exercise capacity in patients with obstructive sleep apnea syndrome. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2007;58(Suppl 5):563–74.

    Google Scholar 

  9. Redeker NS, Hedges C. Sleep during hospitalization and recovery after cardiac surgery. The Journal of cardiovascular nursing. 2002;17:56–68 quiz 82-3.

    Article  PubMed  Google Scholar 

  10. Redeker NS, Ruggiero JS, Hedges C. Sleep is related to physical function and emotional well-being after cardiac surgery. Nurs Res. 2004;53:154–62.

    Article  PubMed  Google Scholar 

  11. Yilmaz H, Iskesen I. Follow-up with objective and subjective tests of the sleep characteristics of patients after cardiac surgery. Circ J. 2007;71:1506–10.

    Article  PubMed  Google Scholar 

  12. Krishnaswamy U, Aneja A, Kumar RM, Kumar TP. Utility of portable monitoring in the diagnosis of obstructive sleep apnea. J Postgrad Med. 2015;61:223–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Flemons WW, Douglas NJ, Kuna ST, Rodenstein DO, Wheatley J. Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med. 2004;169:668–72.

    Article  PubMed  Google Scholar 

  14. Timkova V, Nagyova I, Reijneveld SA, Tkacova R, van Dijk JP, Bultmann U. Psychological distress in patients with obstructive sleep apnoea: the role of hostility and coping self-efficacy. J Health Psychol. 2018;1359105318792080:1–16.

  15. Yamashita MH, Luqman Z, Menkis AH, Arora RC. Coronary artery bypass grafting-the long-term solution? Can J Cardiol. 2018;34:953–5.

    Article  PubMed  Google Scholar 

  16. Buchner S, Greimel T, Hetzenecker A, et al. Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J. 2012;40:1173–9.

    Article  PubMed  Google Scholar 

  17. Schiza SE, Simantirakis E, Bouloukaki I, et al. Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med. 2012;8:21–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Le Grande MR, Jackson AC, Murphy BM, Thomason N. Relationship between sleep disturbance, depression and anxiety in the 12 months following a cardiac event. Psychol Health Med. 2016;21:52–9.

    Article  PubMed  Google Scholar 

  19. Le Grande MR, Neubeck L, Murphy BM, et al. Screening for obstructive sleep apnoea in cardiac rehabilitation: a position statement from the Australian Centre for Heart Health and the Australian cardiovascular health and rehabilitation association. Eur J Prev Cardiol. 2016;23:1466–75.

    Article  PubMed  Google Scholar 

  20. Tietjens JR, Claman D, Kezirian EJ, et al. Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. 2019;8:e010440.

    Article  CAS  PubMed  Google Scholar 

  21. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3:123–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health = Arch Belges de Sante Publique. 2014;72:39.

    Article  Google Scholar 

  24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003;327:557–60.

    Article  Google Scholar 

  25. Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37:1148–57.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997;315:629–34.

    Article  CAS  Google Scholar 

  27. Sert Kuniyoshi FH, Zellmer MR, Calvin AD, et al. Diagnostic accuracy of the Berlin questionnaire in detecting sleep-disordered breathing in patients with a recent myocardial infarction. Chest. 2011;140:1192–7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hupin D, Pichot V, Berger M, et al. Obstructive sleep apnea in cardiac rehabilitation patients. J Clin Sleep Med. 2018;14:1119–26.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Zhao X, Li X, Xu H, et al. Relationships between cardiometabolic disorders and obstructive sleep apnea: implications for cardiovascular disease risk. J Clin Hypertens. 2019;21:280–90.

    Article  CAS  Google Scholar 

  30. Seravalle G, Grassi G. Chapter 18 - role of sympathetic nervous system in the metabolic syndrome and sleep apnea. In: Watson RR, editor. Modulation of sleep by obesity, diabetes, age, and diet. San Diego: Academic Press; 2015. p. 165–75.

    Chapter  Google Scholar 

  31. Kheirandish-Gozal L, Gozal D. Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines. Int J Mol Sci. 2019;20:459.

    Article  CAS  PubMed Central  Google Scholar 

  32. Eisele H-J, Markart P, Schulz R. Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies. Oxid Med Cell Longev. 2015;2015:608438.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Kohler M, Craig S, Nicoll D, Leeson P, Davies RJ, Stradling JR. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med. 2008;178:984–8.

    Article  PubMed  Google Scholar 

  34. Vgontzas AN, Li Y, He F, et al. 0426 mild-to-moderate obstructive sleep apnea is associated with incident hypertension: a longitudinal, population-based study. Sleep. 2017;40:A158–A9.

    Article  Google Scholar 

  35. Garcia-Rio F, Alonso-Fernandez A, Armada E, et al. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol. 2013;168:1328–35.

    Article  PubMed  Google Scholar 

  36. Nakashima H, Kurobe M, Minami K, Furudono S, Uchida Y, Amenomori K. Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2015;4(1):75-84.

  37. Linz D, Baumert M, Catcheside P, et al. Assessment and interpretation of sleep disordered breathing severity in cardiology: clinical implications and perspectives. Int J Cardiol. 2018;271:281–8.

    Article  PubMed  Google Scholar 

  38. Loredo JS, Ziegler MG, Ancoli-Israel S, Clausen JL, Dimsdale JE. Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea. Chest. 1999;116:655–9.

    Article  CAS  PubMed  Google Scholar 

  39. Powell R, McGregor G, Ennis S, Kimani PK, Underwood M. Is exercise-based cardiac rehabilitation effective? Systematic review and meta-analysis to re-examine the evidence. BMJ Open. 2018;8:e019656.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Abell B, Zecchin R, Gallagher R. Making sense of the Unfavourable systematic review of exercise-based cardiac rehabilitation in the modern era: how should we proceed? Heart, lung & circulation 2018.

  41. Khan SU, Duran CA, Rahman H, Lekkala M, Saleem MA, Kaluski E. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea. Eur Heart J. 2018;39(24):2291-7.

  42. Fu Y, Xia Y, Yi H, Xu H, Guan J, Yin S. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath. 2017;21:181–9.

    Article  PubMed  Google Scholar 

  43. Fumagalli S, Tarantini F, Cipriani C, et al. Obstructive sleep apnea after myocardial infarction. Int J Cardiol. 2010;145:550–2.

    Article  PubMed  Google Scholar 

  44. Fox H, Purucker HC, Holzhacker I, et al. Prevalence of sleep-disordered breathing and patient characteristics in a coronary artery disease cohort undergoing cardiovascular rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:421–9.

    Article  PubMed  Google Scholar 

  45. Banack HR, Holly CD, Lowensteyn I, et al. The association between sleep disturbance, depressive symptoms, and health-related quality of life among cardiac rehabilitation participants. J Cardiopulm Rehabil Prev. 2014;34:188–94.

    Article  PubMed  Google Scholar 

  46. Marzolini S, Sarin M, Reitav J, Mendelson M, Oh P. Utility of screening for obstructive sleep apnea in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:413–20.

    Article  PubMed  Google Scholar 

  47. Sharma S, Parker AT. Prevalence of obstructive sleep apnea in a patient population undergoing cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2011;31:188–92.

    Article  PubMed  Google Scholar 

  48. Wada H, Miyauchi K, Daida H. Gender differences in the clinical features and outcomes of patients with coronary artery disease. Expert Rev Cardiovasc Ther. 2019;17:127–33.

    Article  CAS  PubMed  Google Scholar 

  49. Glantz H, Thunstrom E, Herlitz J, et al. Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort. Ann Am Thorac Soc. 2013;10:350–6.

    Article  PubMed  Google Scholar 

  50. Meng S, Fang L, Wang CQ, Wang LS, Chen MT, Huang XH. Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J Int Med Res. 2009;37:1343–53.

    Article  CAS  PubMed  Google Scholar 

  51. Douglas JA, Chai-Coetzer CL, McEvoy D, et al. Guidelines for sleep studies in adults - a position statement of the Australasian Sleep Association. Sleep Med. 2017;36(Suppl 1):S2–S22.

    Article  PubMed  Google Scholar 

  52. Loo G, Chua AP, Tay HY, Poh R, Tai BC, Lee CH. Sleep-disordered breathing in cardiac rehabilitation: prevalence, predictors, and influence on the six-minute walk test. Heart Lung Circ. 2016;25:584–91.

    Article  PubMed  Google Scholar 

  53. Hargens TA, Aron A, Newsome LJ, Austin JL, Shafer BM. Effects of obstructive sleep apnea on hemodynamic parameters in patients entering cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2015;35:181–5.

    Article  PubMed  Google Scholar 

  54. Skobel E, Kamke W, Bonner G, et al. Risk factors for, and prevalence of, sleep apnoea in cardiac rehabilitation facilities in Germany: the Reha-sleep registry. Eur J Prev Cardiol. 2015;22:820–30.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Not Applicable.

Funding

Professor Andrea Driscoll was supported by a Heart Foundation Future Leader fellowship 100472 from the National Heart Foundation of Australia.

Author information

Authors and Affiliations

  1. Australian Centre for Heart Health, 75 Chetwynd Street, North Melbourne, VIC, 3051, Australia

    Michael R. Le Grande, Alison Beauchamp & Alun C. Jackson

  2. Faculty of Health, Deakin University, Burwood, VIC, 3216, Australia

    Michael R. Le Grande & Alun C. Jackson

  3. Melbourne Centre for Behaviour Change, School of Psychological Sciences, The University of Melbourne, Parkville, VIC, 3052, Australia

    Michael R. Le Grande

  4. Department of Medicine -Western Health, The University of Melbourne, Parkville, VIC, 3052, Australia

    Alison Beauchamp

  5. Australian Institute for Musculoskeletal Science (AIMSS), St.Albans, VIC, 3021, Australia

    Alison Beauchamp

  6. School of Rural Health, Monash University, Newborough, VIC, 3825, Australia

    Alison Beauchamp

  7. Centre for Quality and Patient Safety Research, School of Nursing and Midwifery, Deakin University, Geelong, VIC, 3220, Australia

    Andrea Driscoll

  8. Centre on Behavioural Health, Hong Kong University, Pakfulam, Hong Kong

    Alun C. Jackson

Authors
  1. Michael R. Le Grande
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alison Beauchamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Driscoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alun C. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MLG, AJ, AB, AD contributed to the conception of the study and participated in writing of the manuscript. MLG: performed the literature search, and meta-analysis. All authors screened publications and selected eligible studies. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Michael R. Le Grande.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items addressed in our systematic review and meta-analysis.

Additional file 2.

Search strategy.

Additional file 3.

Quality ratings for prevalence studies.

Additional file 4.

Details of publications providing a prevalence estimate.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le Grande, M.R., Beauchamp, A., Driscoll, A. et al. Prevalence of obstructive sleep apnoea in acute coronary syndrome patients: systematic review and meta-analysis. BMC Cardiovasc Disord 20, 147 (2020). https://doi.org/10.1186/s12872-020-01430-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-020-01430-3

Keywords

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us